Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

European Journal of Clinical Pharmacology

Volumn 67, Issue 4, 2011, Pages 365-370

  Silva, Pamela S ^a   Fontana, Vanessa ^b   Palei, Ana C T ^a   Sertório, Jonas T C ^a   Biagi, Celso ^c   Tanus Santos, Jose Eduardo ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Santa Casa of Aracatuba   (Brazil)

Author keywords

ACE inhibitors; Enalapril; Hypertension; Nitric oxide; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ENALAPRIL; NITRATE; NITRIC OXIDE; NITRITE; OZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; TREATMENT DURATION; VENOUS BLOOD;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOMARKERS, PHARMACOLOGICAL; BLOOD PRESSURE; DINOPROST; ENALAPRIL; HUMANS; HYPERTENSION; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 79954475277     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-011-1003-x     Document Type: Article

References (39)

1. K Hanif HK Bid R Konwar 2010 Reinventing the ACE inhibitors: some old and new implications of ACE inhibition Hypertens Res 33 1 11 21 19911001 10.1038/hr.2009.184 1:CAS:528:DC%2BC3cXpt1yi
2. JV Gainer JD Morrow A Loveland DJ King NJ Brown 1998 Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects N Engl J Med 339 18 1285 1292 9791144 10.1056/NEJM199810293391804 1:CAS:528:DyaK1cXnt12kt7Y%3D (Pubitemid 28496194)
3. W Linz P Wohlfart BA Scholkens T Malinski G Wiemer 1999 Interactions among ACE, kinins and NO Cardiovasc Res 43 3 549 561 10690327 10.1016/S0008-6363(99)00091-7 1:CAS:528:DyaK1MXlslCks7w%3D (Pubitemid 29369254)
4. GB Mancini GC Henry C Macaya BJ O'Neill AL Pucillo RG Carere TJ Wargovich H Mudra TF Luscher MI Klibaner HE Haber AC Uprichard CJ Pepine B Pitt 1996 Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study Circulation 94 3 258 265 8759064 1:CAS:528:DyaK28XltF2rsro%3D (Pubitemid 26266107)
5. ME Moreau N Garbacki G Molinaro NJ Brown F Marceau A Adam 2005 The kallikrein-kinin system: current and future pharmacological targets J Pharmacol Sci 99 1 6 38 16177542 10.1254/jphs.SRJ05001X 1:CAS:528:DC%2BD2MXhtVOqsrrN (Pubitemid 41366887)
6. C Tschope HP Schultheiss T Walther 2002 Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade J Cardiovasc Pharmacol 39 4 478 487 11904521 10.1097/00005344-200204000-00003 1:CAS:528:DC%2BD38Xis1Onsbc%3D (Pubitemid 34252382)
7. C Ceconi KM Fox WJ Remme ML Simoons M Bertrand G Parrinello C Kluft A Blann D Cokkinos R Ferrari 2007 ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT Cardiovasc Res 73 1 237 246 17140552 10.1016/j.cardiores.2006.10.021 1:CAS:528:DC%2BD2sXpvVGn (Pubitemid 44937193)
8. G Di Girolamo E Gonzalez D Livio AR de los Santos ML Marti MA de Gimeno 2002 The effect of enalapril on PGI(2) and NO levels in hypertensive patients Prostaglandins Leukot Essent Fatty Acids 66 5-6 493 498 12144869 10.1054/plef.2002.0388
9. M Kohno K Yokokawa M Minami K Yasunari K Maeda H Kano T Hanehira J Yoshikawa 1999 Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension Metabolism 48 10 1256 1259 10535387 10.1016/S0026-0495(99)90264-0 1:CAS:528:DyaK1MXmslGjur4%3D (Pubitemid 29496072)
10. O Suda M Tsutsui T Morishita M Horiuchi S Nakata R Kouzuma M Okazaki A Sumiyama-Fujinishi T Mizuki N Yanagihara H Tasaki Y Nakashima 2006 Long-term treatment with imidapril but not with nifedipine enhances plasma NOx concentration in patients with essential hypertension J Pharmacol Sci 101 2 159 165 16766855 10.1254/jphs.FP0060031 1:CAS:528:DC%2BD28XmslWrsbg%3D (Pubitemid 43938767)
11. H Takase M Sugiyama A Nakazawa K Sato R Ueda Y Dohi 2000 Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension Arzneimittelforschung 50 6 530 534 10918945 1:CAS:528:DC%2BD3cXkvFCns78%3D (Pubitemid 30418408)
12. D Yavuz M Koc A Toprak I Akpinar A Velioglu O Deyneli G Haklar S Akalin 2003 Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients J Renin Angiotensin Aldosterone Syst 4 3 197 203 14608527 10.3317/jraas.2003.032 1:CAS:528:DC%2BD3sXpsFCmt7Y%3D (Pubitemid 37407169)
13. G Ellis I Adatia M Yazdanpanah SK Makela 1998 Nitrite and nitrate analyses: a clinical biochemistry perspective Clin Biochem 31 4 195 220 9646943 10.1016/S0009-9120(98)00015-0 1:CAS:528:DyaK1cXktlejsrg%3D (Pubitemid 28285351)
14. M Kelm H Preik-Steinhoff M Preik BE Strauer 1999 Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway Cardiovasc Res 41 3 765 772 10435049 10.1016/S0008-6363(98)00259-4 1:CAS:528:DyaK1MXhvVGhtLk%3D (Pubitemid 29130641)
15. IF Metzger JT Sertorio JE Tanus-Santos 2006 Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers Acta Physiol Oxf 188 2 123 127 16948799 10.1111/j.1748-1716.2006.01612.x 1:CAS:528:DC%2BD28XhtVCnsr3N (Pubitemid 44337809)
16. P Kleinbongard A Dejam T Lauer T Jax S Kerber P Gharini J Balzer RB Zotz RE Scharf R Willers AN Schechter M Feelisch M Kelm 2006 Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans Free Radic Biol Med 40 2 295 302 16413411 10.1016/j.freeradbiomed.2005.08.025 1:CAS:528:DC%2BD28XksVehtQ%3D%3D (Pubitemid 43069353)
17. T Rassaf C Heiss U Hendgen-Cotta J Balzer S Matern P Kleinbongard A Lee T Lauer M Kelm 2006 Plasma nitrite reserve and endothelial function in the human forearm circulation Free Radic Biol Med 41 2 295 301 16814110 10.1016/j.freeradbiomed.2006.04.006 1:CAS:528:DC%2BD28Xmt1Orsbc%3D (Pubitemid 43928502)
18. T Lauer M Preik T Rassaf BE Strauer A Deussen M Feelisch M Kelm 2001 Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action Proc Natl Acad Sci USA 98 22 12814 12819 11606734 10.1073/pnas.221381098 1:CAS:528:DC%2BD3MXotFahsLw%3D (Pubitemid 33020027)
19. S Nagassaki JT Sertorio IF Metzger AF Bem JB Rocha JE Tanus-Santos 2006 eNOS gene T-786 C polymorphism modulates atorvastatin-induced increase in blood nitrite Free Radic Biol Med 41 7 1044 1049 16962929 10.1016/j.freeradbiomed. 2006.04.026 1:CAS:528:DC%2BD28XpsVOiu74%3D (Pubitemid 44331568)
20. SB Cau CA Dias-Junior MF Montenegro G de Nucci E Antunes JE Tanus-Santos 2008 Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism Eur J Pharmacol 581 1-2 132 137 18076875 10.1016/j.ejphar.2007.11.030 1:CAS:528:DC%2BD1cXhsVCnu7o%3D
21. VC Sandrim MF Montenegro AC Palei IF Metzger JT Sertorio RC Cavalli JE Tanus-Santos 2010 Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia Free Radic Biol Med 49 3 493 500 20510352 10.1016/j.freeradbiomed.2010.05.012 1:CAS:528:DC%2BC3cXotVequ70%3D
22. MF Montenegro LR Pessa VA Gomes Z Desta DA Flockhart JE Tanus-Santos 2009 Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed Basic Clin Pharmacol Toxicol 104 5 400 407 19413660 10.1111/j.1742-7843.2009.00377.x 1:CAS:528:DC%2BD1MXnt1CltLo%3D
23. IF Metzger JT Sertorio JE Tanus-Santos 2007 Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes Free Radic Biol Med 43 6 987 992 17697943 10.1016/j.freeradbiomed.2007.06.012 1:CAS:528:DC%2BD2sXovFOqurc%3D (Pubitemid 47223635)
24. C Napoli G Bruzzese LJ Ignarro E Crimi F de Nigris S Williams-Ignarro S Libardi L Sommese C Fiorito FP Mancini F Cacciatore A Liguori 2008 Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension Am Heart J 156 6 1154 e1151 1158 10.1016/j.ahj.2008.09.006
25. C Napoli V Sica F de Nigris O Pignalosa M Condorelli LJ Ignarro A Liguori 2004 Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension Am Heart J 148 1 e5 15215814 10.1016/j.ahj.2004.03.025 1:STN:280:DC%2BD2czhtlSqug%3D%3D (Pubitemid 38900498)
26. T Lauer P Kleinbongard M Kelm 2002 Indexes of NO bioavailability in human blood News Physiol Sci 17 251 255 12433980 1:CAS:528:DC%2BD38Xpsleltbs%3D (Pubitemid 36015534)
27. P Kleinbongard A Dejam T Lauer T Rassaf A Schindler O Picker T Scheeren A Godecke J Schrader R Schulz G Heusch GA Schaub NS Bryan M Feelisch M Kelm 2003 Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals Free Radic Biol Med 35 7 790 796 14583343 10.1016/S0891-5849(03)00406-4 1:CAS:528:DC%2BD3sXosVKnsLw%3D (Pubitemid 37329482)
28. T Bachetti L Comini E Pasini A Cargnoni S Curello R Ferrari 2001 Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats J Mol Cell Cardiol 33 3 395 403 11181009 10.1006/jmcc.2000.1311 1:CAS:528:DC%2BD3MXht1aqtrk%3D (Pubitemid 32538997)
29. L Comini T Bachetti A Cargnoni D Bastianon GL Gitti C Ceconi R Ferrari 2007 Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent Pharmacol Res 56 1 42 48 17475504 10.1016/j.phrs.2007.03.004 1:CAS:528:DC%2BD2sXntFyhsbc%3D (Pubitemid 46990929)
30. CV De Gennaro A Rigamonti S Fioretti S Bonomo B Manfredi P Ferrario M Bianchi F Berti EE Muller G Rossoni 2005 Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats Eur J Pharmacol 516 3 253 259 10.1016/j.ejphar.2005.04.004 (Pubitemid 40922746)
31. JL Miguel-Carrasco MT Monserrat A Mate CM Vazquez 2010 Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats Eur J Pharmacol 632 1-3 65 72 20123095 10.1016/j.ejphar.2010.01.017 1:CAS:528: DC%2BC3cXivFKhu7k%3D
32. JC Hartman 1995 The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors Ann Thorac Surg 60 3 789 792 7545893 10.1016/0003-4975(95)00192-N 1:STN:280:DyaK2MvgvVSnsQ%3D%3D
33. XP Yang YH Liu EG Shesely M Bulagannawar F Liu OA Carretero 1999 Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury Hypertension 34 1 24 30 10406819 1:CAS:528:DyaK1MXkvFejtbg%3D (Pubitemid 29325714)
34. IF Metzger DC Souza-Costa AS Marroni S Nagassaki Z Desta DA Flockhart JE Tanus-Santos 2005 Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men Pharmacogenet Genomics 15 8 565 570 16007000 10.1097/01.fpc.0000167328.85163.44 1:CAS:528:DC%2BD2MXmtVSnt70%3D (Pubitemid 41044242)
35. VC Sandrim RW de Syllos HR Lisboa GS Tres JE Tanus-Santos 2007 Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients Nitric Oxide 16 3 348 355 17306574 10.1016/j.niox.2006.12.007 1:CAS:528:DC%2BD2sXjvFegsL0%3D (Pubitemid 46528773)
36. VC Sandrim AC Palei JT Sertorio RC Cavalli G Duarte JE Tanus-Santos 2010 Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia Mol Hum Reprod 16 7 506 510 20457799 10.1093/molehr/gaq030 1:CAS:528:DC%2BC3cXnsVyjsbw%3D
37. R Lacchini PS Silva JE Tanus-Santos 2010 A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins Basic Clin Pharmacol Toxicol 106 5 357 361 20210789 1:CAS:528: DC%2BC3cXlslSgsrg%3D
38. S Nagassaki RD Herculano CF Graeff JE Tanus-Santos 2009 eNOS T-786 C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity Eur J Clin Pharmacol 65 4 385 392 19104789 10.1007/s00228-008-0602-7 1:CAS:528:DC%2BD1MXjt1Shsrw%3D
39. DC Souza-Costa VC Sandrim LF Lopes RF Gerlach EM Rego JE Tanus-Santos 2007 Anti-inflammatory effects of atorvastatin: modulation by the T-786 C polymorphism in the endothelial nitric oxide synthase gene Atherosclerosis 193 2 438 444 16938300 10.1016/j.atherosclerosis.2006.07.020 1:CAS:528: DC%2BD2sXotVCltr4%3D (Pubitemid 47058109)